Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates

Go back to Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates
(NASDAQ: RANI) Delayed: 0.85 -0.04 (4.49%)
Previous Close $0.89    52 Week High
Open $0.87    52 Week Low
Day High $0.95    P/E N/A 
Day Low $0.84    EPS
Volume 1,443,429